drugset / Trial / NCT01568762
To Compare the Safety, Tolerability, and Pharmacokinetics of QBX258 in Patients With Asthma
RandomizedParallel-groupDouble-blindOther
Summary
This study is designed to compare the safety, tolerability, and pharmacokinetics of QBX258 (sequential administration of a fixed dose of VAK694 and single ascending doses of QAX576) in patients with well-controlled mild to moderate asthma.
Timeline
- Start
- 2010-10
- Primary completion
- 2011-07
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | QAX576 | Monoclonal antibody | — | Intravenous |
| Subject | VAK694 | Unknown | — | Intravenous |